drugset / Trial / NCT00752180
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
RandomizedCrossoverQuadruple-blindHealth-services research
Summary
The aim of this trial is to demonstrate bioequivalence of Wosulin R to Actrapid with regard to its total and to its maximum serum insulin concentrations.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-03
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |
| Subject | Wosulin R | Protein / enzyme biologic | 0.3 iu/kg | Subcutaneous |